306 related articles for article (PubMed ID: 25376296)
21. Clinical implications of cancer stem cell biology in hepatocellular carcinoma.
Ji J; Wang XW
Semin Oncol; 2012 Aug; 39(4):461-72. PubMed ID: 22846863
[TBL] [Abstract][Full Text] [Related]
22. Investigation of diagnostic utility and expression profiles of stem cell markers (CD133 and CD90) in hepatocellular carcinoma, small cell dysplasia, and cirrhosis.
Yilmaz G; Akyol G; Cakir A; Ilhan M
Pathol Res Pract; 2014 Jul; 210(7):419-25. PubMed ID: 24702884
[TBL] [Abstract][Full Text] [Related]
23. Keratin 19 protein expression is an independent predictor of survival in human hepatocellular carcinoma.
Fatourou E; Koskinas J; Karandrea D; Palaiologou M; Syminelaki T; Karanikolas M; Felekouras E; Antoniou E; Manesis EK; Delladetsima J; Tiniakos D
Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1094-102. PubMed ID: 26011233
[TBL] [Abstract][Full Text] [Related]
24. Genetic alterations and expression of PTEN and its relationship with cancer stem cell markers to investigate pathogenesis and to evaluate prognosis in hepatocellular carcinoma.
Chen D; Li Z; Cheng Q; Wang Y; Qian L; Gao J; Zhu JY
J Clin Pathol; 2019 Sep; 72(9):588-596. PubMed ID: 31126975
[TBL] [Abstract][Full Text] [Related]
25. EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma.
Terris B; Cavard C; Perret C
J Hepatol; 2010 Feb; 52(2):280-1. PubMed ID: 20006402
[TBL] [Abstract][Full Text] [Related]
26. Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma.
Song W; Li H; Tao K; Li R; Song Z; Zhao Q; Zhang F; Dou K
Int J Clin Pract; 2008 Aug; 62(8):1212-8. PubMed ID: 18479363
[TBL] [Abstract][Full Text] [Related]
27. Surface markers of hepatocellular cancer stem cells and their clinical potential.
Feng D; Wang N; Hu J; Li W
Neoplasma; 2014; 61(5):505-13. PubMed ID: 24712843
[TBL] [Abstract][Full Text] [Related]
28. Stemness characteristics of fibrolamellar hepatocellular carcinoma: immunohistochemical analysis with comparisons to conventional hepatocellular carcinoma.
Zenali MJ; Tan D; Li W; Dhingra S; Brown RE
Ann Clin Lab Sci; 2010; 40(2):126-34. PubMed ID: 20421623
[TBL] [Abstract][Full Text] [Related]
29. High expression of MAGE-A9 contributes to stemness and malignancy of human hepatocellular carcinoma.
Wei Y; Wang Y; Gong J; Rao L; Wu Z; Nie T; Shi D; Zhang L
Int J Oncol; 2018 Jan; 52(1):219-230. PubMed ID: 29138811
[TBL] [Abstract][Full Text] [Related]
30. Clinico-Radio-Pathological and Molecular Features of Hepatocellular Carcinomas with Keratin 19 Expression.
Rhee H; Kim H; Park YN
Liver Cancer; 2020 Dec; 9(6):663-681. PubMed ID: 33442539
[TBL] [Abstract][Full Text] [Related]
31. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
32. Hypoxia after transarterial chemoembolization may trigger a progenitor cell phenotype in hepatocellular carcinoma.
Lai JP; Conley A; Knudsen BS; Guindi M
Histopathology; 2015 Oct; 67(4):442-50. PubMed ID: 25425262
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of MAGE-D4 expression in hepatocellular carcinoma in Japanese patients.
Takami H; Kanda M; Oya H; Hibino S; Sugimoto H; Suenaga M; Yamada S; Nishikawa Y; Asai M; Fujii T; Nomoto S; Kodera Y
J Surg Oncol; 2013 Dec; 108(8):557-62. PubMed ID: 24068544
[TBL] [Abstract][Full Text] [Related]
34. MRI features of hepatocellular carcinoma expressing progenitor cell markers.
Jeong HT; Kim MJ; Kim YE; Park YN; Choi GH; Choi JS
Liver Int; 2012 Mar; 32(3):430-40. PubMed ID: 22097930
[TBL] [Abstract][Full Text] [Related]
35. EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.
Yamashita T; Forgues M; Wang W; Kim JW; Ye Q; Jia H; Budhu A; Zanetti KA; Chen Y; Qin LX; Tang ZY; Wang XW
Cancer Res; 2008 Mar; 68(5):1451-61. PubMed ID: 18316609
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathological indices to predict hepatocellular carcinoma molecular classification.
Tan PS; Nakagawa S; Goossens N; Venkatesh A; Huang T; Ward SC; Sun X; Song WM; Koh A; Canasto-Chibuque C; Deshmukh M; Nair V; Mahajan M; Zhang B; Fiel MI; Kobayashi M; Kumada H; Hoshida Y
Liver Int; 2016 Jan; 36(1):108-18. PubMed ID: 26058462
[TBL] [Abstract][Full Text] [Related]
37. Childhood hepatocellular carcinoma: a clinicopathological study of 12 cases with special reference to EpCAM.
Zen Y; Vara R; Portmann B; Hadzic N
Histopathology; 2014 Apr; 64(5):671-82. PubMed ID: 24138022
[TBL] [Abstract][Full Text] [Related]
38. Increased expression of stemness markers and altered tumor stroma in hepatocellular carcinoma under TACE-induced hypoxia: A biopsy and resection matched study.
Nahm JH; Rhee H; Kim H; Yoo JE; San Lee J; Jeon Y; Choi GH; Park YN
Oncotarget; 2017 Nov; 8(59):99359-99371. PubMed ID: 29245907
[TBL] [Abstract][Full Text] [Related]
39. SALL4 Expression in Hepatocellular Carcinomas Is Associated with EpCAM-Positivity and a Poor Prognosis.
Park H; Lee H; Seo AN; Cho JY; Choi YR; Yoon YS; Han HS; Park YN; Kim H
J Pathol Transl Med; 2015 Sep; 49(5):373-81. PubMed ID: 26265684
[TBL] [Abstract][Full Text] [Related]
40. An EpCAM/CD3 bispecific antibody efficiently eliminates hepatocellular carcinoma cells with limited galectin-1 expression.
Zhang P; Shi B; Gao H; Jiang H; Kong J; Yan J; Pan X; Li K; Zhang P; Yao M; Yang S; Gu J; Wang H; Li Z
Cancer Immunol Immunother; 2014 Feb; 63(2):121-32. PubMed ID: 24177984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
